Skip to main content
Division of Cancer Prevention
Division of Cancer Prevention

Search form

Main menu

  • Home
  • Major Programs
    • Cancer Prevention Fellowship Program (CPFP)
    • Early Detection Research Network (EDRN)
    • NCI Community Oncology Research Program (NCORP)
    • Adductomics Research Program (ARP)
    • Alliance of Glycobiologists for Cancer Research
    • Barrett's Esophagus Translational Research Network (BETRNet)
    • Cancer Prevention Clinical Trials Network (CP-CTNet)
    • Consortium for Imaging and Biomarkers (CIB)
    • Liquid Biopsy Consortium
    • Pancreatic Cancer Detection Consortium (PCDC)
    • Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)
    • PREVENT Cancer Preclinical Drug Development Program (PREVENT)
    • Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection
    • Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
    • Small Cell Lung Cancer (SCLC) Consortium
    • Supportive Care and Symptom Management
    • Translational Liver Cancer (TLC) Consortium
    • US-Latin American-Caribbean Clinical Trials Network (ULACNet)
    • Research Networks Map
  • Research Groups
    • Biometry
    • Breast and Gynecologic Cancer
    • Cancer Biomarkers
    • Chemopreventive Agent Development
    • Community Oncology and Prevention Trials
    • Early Detection
    • Gastrointestinal and Other Cancers
    • Lung and Upper Aerodigestive Cancer
    • Nutritional Science
    • Prostate and Urologic Cancer
  • Clinical Trials
    • Clinical Trials Search
    • Featured Trials
    • Landmark Trials
    • Clinical Trials Management
  • Funding & Grants
    • Funding Opportunities
    • Funded Grants
    • Grantsmanship Resources
  • Resources
    • Publication Search
    • Biorepositories
    • Cancer Data Access System
  • News & Events
    • News
    • Blog
    • Meetings and Events
    • Videos and Webinars
    • Infographics
  • About DCP
    • Scientific Scope
    • DCP Leadership
    • History and Timeline
    • Staff Directory
    • Contact DCP

You are here

  1. Home
  2.   »  Research Groups
  3.   »  Early Detection

Early Detection

Early Detection

Early Detection

The Early Detection Research Group supports research that seeks to determine the effectiveness, operating characteristics, and clinical impact (harms as well as benefits) of cancer early detection technologies and practices, such as imaging and molecular biomarker approaches.

Read more About the Early Detection Research Group.

Staff

Funding Opportunities

Active Grants

Publications

News

Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)

A large randomized trial designed to determine the effects of screening on cancer-related mortality and secondary endpoints in people aged 55 to 74. Researchers can request valuable PLCO data and biospecimens.

Learn more about the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)

Cancer Data Access System (CDAS)

Submission and tracking for data from the National Lung Screening Trial and the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

The National Lung Screening Trial (NLST)

A lung cancer screening trial that compared two ways of detecting lung cancer: low-dose helical (spiral) computed tomography (CT) and standard chest x-ray. Researchers can request NLST data sets, CT images, and pathology images.

11th NCI EDRN Scientific Workshop

The 11th NCI EDRN Scientific Workshop to be held in Bethesda North Marriott Hotel from September 9 through September 12, 2019.

Research Groups

  • Biometry
  • Breast and Gynecologic Cancer
  • Cancer Biomarkers
  • Chemopreventive Agent Development
  • Community Oncology and Prevention Trials
  • Early Detection
    • 11th NCI EDRN Scientific Workshop
    • About the Early Detection Research Group
    • Active Grants
    • Funding Opportunities
    • Publications
    • Staff
  • Gastrointestinal and Other Cancers
  • Lung and Upper Aerodigestive Cancer
  • Nutritional Science
  • Prostate and Urologic Cancer

Contact the Early Detection Research Group

Phone: (240) 276-7060
Fax: (240) 276-7848

For Regular Mail

Early Detection Research Group
Division of Cancer Prevention National Cancer Institute
9609 Medical Center Drive
MSC 9781
Bethesda, MD 20892-9781

For Courier Packages

Early Detection Research Group
Division of Cancer Prevention National Cancer Institute
9609 Medical Center Drive
Rockville, MD 20850

Follow us at:

@NCI Prevention

@NCI Supportive Care

The National Cancer Institute

Policies

DCP Home

Contact DCP

Policies

Accessibility

FOIA

NCI's PDQ® Evidence-based Summaries

Cancer Prevention

Screening/Detection/Testing for Cancer

Supportive and Palliative Care

General Information

Cancer Prevention, Specific Cancers, Clinical Trials

Cancer Screening Topics For People Who Have No Symptoms

Managing The Side Effects of Cancer and Its Treatment

Coping With Cancer

US Preventive Services Task Force Recommendations About Cancer

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®